Daniel Senfter

650 total citations
19 papers, 417 citations indexed

About

Daniel Senfter is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Daniel Senfter has authored 19 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Daniel Senfter's work include Extracellular vesicles in disease (6 papers), Glioma Diagnosis and Treatment (4 papers) and MicroRNA in disease regulation (3 papers). Daniel Senfter is often cited by papers focused on Extracellular vesicles in disease (6 papers), Glioma Diagnosis and Treatment (4 papers) and MicroRNA in disease regulation (3 papers). Daniel Senfter collaborates with scholars based in Austria, Germany and United States. Daniel Senfter's co-authors include Georg Krupitza, Robert M. Mader, Sibylle Madlener, Nicole Huttary, Walter Jäger, Helmut Dolznig, Thomas Ströbel, Okay Saydam, Nurten Saydam and Erdoğan Pekcan Erkan and has published in prestigious journals such as The Journal of Cell Biology, Analytical Chemistry and Human Molecular Genetics.

In The Last Decade

Daniel Senfter

18 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Senfter Austria 10 330 233 47 46 33 19 417
Octavio Galindo‐Hernández Mexico 12 304 0.9× 228 1.0× 67 1.4× 41 0.9× 40 1.2× 26 433
Shentong Yu China 8 452 1.4× 342 1.5× 73 1.6× 22 0.5× 25 0.8× 11 524
Xingmei Zhu China 9 400 1.2× 291 1.2× 67 1.4× 19 0.4× 25 0.8× 17 513
Andréia Hanada Otake Brazil 12 194 0.6× 61 0.3× 52 1.1× 56 1.2× 33 1.0× 25 318
Amirabbas Kakavand Iran 11 367 1.1× 239 1.0× 126 2.7× 45 1.0× 25 0.8× 14 530
Annick Notte Belgium 6 268 0.8× 185 0.8× 92 2.0× 33 0.7× 27 0.8× 6 475
Nurmaa K. Dashzeveg Japan 10 243 0.7× 141 0.6× 130 2.8× 31 0.7× 20 0.6× 12 368
Filipa Martins Portugal 8 205 0.6× 135 0.6× 93 2.0× 41 0.9× 47 1.4× 13 378

Countries citing papers authored by Daniel Senfter

Since Specialization
Citations

This map shows the geographic impact of Daniel Senfter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Senfter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Senfter more than expected).

Fields of papers citing papers by Daniel Senfter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Senfter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Senfter. The network helps show where Daniel Senfter may publish in the future.

Co-authorship network of co-authors of Daniel Senfter

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Senfter. A scholar is included among the top collaborators of Daniel Senfter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Senfter. Daniel Senfter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Minichmayr, Iris K., Johannes Gojo, Daniel Senfter, et al.. (2024). Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors. Pediatric Drugs. 26(4). 429–440. 1 indexed citations
2.
Maaß, Kendra K., Petra Pokorná, O. Saijonmaa, et al.. (2024). BIOM-09. TOWARDS CLINICAL IMPLEMENTATION OF LIQUID BIOPSY ANALYSIS FOR PAEDIATRIC BRAIN TUMOUR PATIENTS – A PAN-EUROPEAN EFFORT FOR STANDARDIZATION. Neuro-Oncology. 26(Supplement_4). 0–0.
3.
Senfter, Daniel, Julia Furtner, Christine Haberler, et al.. (2023). Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR. Cancers. 15(9). 2525–2525. 8 indexed citations
4.
Madlener, Sibylle, Julia Furtner, Daniel Senfter, et al.. (2023). Clinical applicability of miR517a detection in liquid biopsies of ETMR patients. Acta Neuropathologica. 145(6). 843–846. 3 indexed citations
5.
Maaß, Kendra K., Torsten Mueller, Daniel Senfter, et al.. (2022). EPEN-28. Oncogenic dependency of pediatric ependymomas on extracellular vesicle pathways. Neuro-Oncology. 24(Supplement_1). i45–i45. 1 indexed citations
6.
Senfter, Daniel, Sibylle Madlener, Christine Häfner, et al.. (2022). Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma. Journal of Cellular Biochemistry. 123(10). 1663–1673. 4 indexed citations
7.
Pinter, Matthias, Daniel Senfter, Sibylle Madlener, et al.. (2021). Cytotoxic Activity of Piperazin-2-One-Based Structures: Cyclic Imines, Lactams, Aminophosphonates, and Their Derivatives. Materials. 14(9). 2138–2138. 7 indexed citations
8.
Pinter, Matthias, Daniel Senfter, Sibylle Madlener, et al.. (2020). Synthesis and Cytotoxic Activity of Chiral Sulfonamides Based on the 2-Azabicycloalkane Skeleton. Molecules. 25(10). 2355–2355. 9 indexed citations
9.
Senfter, Daniel, Robert M. Mader, Johannes Gojo, et al.. (2019). High impact of miRNA-4521 on FOXM1 expression in medulloblastoma. Cell Death and Disease. 10(10). 696–696. 29 indexed citations
10.
Brown, Markus, Louise A. Johnson, Peter Májek, et al.. (2018). Lymphatic exosomes promote dendritic cell migration along guidance cues. The Journal of Cell Biology. 217(6). 2205–2221. 57 indexed citations
11.
Stübiger, Gerald, et al.. (2018). MALDI-MS Protein Profiling of Chemoresistance in Extracellular Vesicles of Cancer Cells. Analytical Chemistry. 90(22). 13178–13182. 20 indexed citations
12.
Brenner, Stefan, Atanas G. Atanasov, Daniel Senfter, et al.. (2017). Intravasation of SW620 colon cancer cell spheroids through the blood endothelial barrier is inhibited by clinical drugs and flavonoids in vitro. Food and Chemical Toxicology. 111. 114–124. 17 indexed citations
13.
Senfter, Daniel, Erdoğan Pekcan Erkan, Erdener Özer, et al.. (2017). Overexpression of minichromosome maintenance protein 10 in medulloblastoma and its clinical implications. Pediatric Blood & Cancer. 64(12). 8 indexed citations
14.
Senfter, Daniel, Chi Huu Nguyen, Silvana Geleff, et al.. (2016). Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro. Oncology Reports. 36(5). 3065–3071. 29 indexed citations
15.
Erkan, Erdoğan Pekcan, Daniel Senfter, Sibylle Madlener, et al.. (2016). Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo. Cancer Gene Therapy. 24(1). 38–44. 47 indexed citations
16.
Senfter, Daniel, Sibylle Madlener, Georg Krupitza, & Robert M. Mader. (2016). The microRNA-200 family: still much to discover. BioMolecular Concepts. 7(5-6). 311–319. 72 indexed citations
17.
Senfter, Daniel, Angelika Walzl, Nicole Huttary, et al.. (2015). Loss of miR-200 family in 5-fluorouracil resistant colon cancer drives lymphendothelial invasiveness in vitro. Human Molecular Genetics. 24(13). 3689–98. 69 indexed citations
18.
Senfter, Daniel & Robert M. Mader. (2015). Exosomes as novel biomarkers in anticancer therapy. memo - Magazine of European Medical Oncology. 8(4). 231–234. 2 indexed citations
19.
Nguyen, Chi Huu, Daniel Senfter, José Basílio, et al.. (2015). NF-κB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro. Oncotarget. 6(36). 39262–39275. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026